OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!
If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.
Requested Article:
A randomized phase 2b trial examined the effects of the glucagon-like peptide-1 and glucagon receptor agonist cotadutide on kidney outcomes in patients with diabetic kidney disease
Viknesh Selvarajah, Darren Robertson, Lars Hansen, et al.
Kidney International (2024) Vol. 106, Iss. 6, pp. 1170-1180
Open Access | Times Cited: 6
Viknesh Selvarajah, Darren Robertson, Lars Hansen, et al.
Kidney International (2024) Vol. 106, Iss. 6, pp. 1170-1180
Open Access | Times Cited: 6
Showing 6 citing articles:
Glucagon-like peptide 1 (GLP-1) receptor agonists for people with chronic kidney disease and diabetes
Patrizia Natale, Suetonia C. Green, David J. Tunnicliffe, et al.
Cochrane library (2025) Vol. 2025, Iss. 2
Closed Access | Times Cited: 1
Patrizia Natale, Suetonia C. Green, David J. Tunnicliffe, et al.
Cochrane library (2025) Vol. 2025, Iss. 2
Closed Access | Times Cited: 1
The pharmacodynamics-based prophylactic benefits of GLP-1 receptor agonists and SGLT2 inhibitors on neurodegenerative diseases: evidence from a network meta-analysis
Ping‐Tao Tseng, Bing‐Yan Zeng, Chih-Wei Hsu, et al.
BMC Medicine (2025) Vol. 23, Iss. 1
Open Access | Times Cited: 1
Ping‐Tao Tseng, Bing‐Yan Zeng, Chih-Wei Hsu, et al.
BMC Medicine (2025) Vol. 23, Iss. 1
Open Access | Times Cited: 1
Innovative Drugs First Implemented in Type 2 Diabetes Mellitus and Obesity and Their Effects on Metabolic Dysfunction-Associated Steatohepatitis (MASH)-Related Fibrosis and Cirrhosis
Georgiana-Diana Cazac, C.M. Lǎcǎtusu, Elena-Daniela Grigorescu, et al.
Journal of Clinical Medicine (2025) Vol. 14, Iss. 4, pp. 1042-1042
Open Access
Georgiana-Diana Cazac, C.M. Lǎcǎtusu, Elena-Daniela Grigorescu, et al.
Journal of Clinical Medicine (2025) Vol. 14, Iss. 4, pp. 1042-1042
Open Access
The combination of SGLT2 inhibitors and glucagon-like peptide 1 receptor agonists: are 2 drugs better than 1?
T. Alp İkizler
Kidney International (2025) Vol. 107, Iss. 3, pp. 385-388
Closed Access
T. Alp İkizler
Kidney International (2025) Vol. 107, Iss. 3, pp. 385-388
Closed Access
The effect of retatrutide on kidney parameters in participants with type 2 diabetes and/or obesity
Hiddo J.L. Heerspink, Zeqing Lu, Yu Du, et al.
Kidney International Reports (2025)
Open Access
Hiddo J.L. Heerspink, Zeqing Lu, Yu Du, et al.
Kidney International Reports (2025)
Open Access
INNOVATIVE THERAPEUTICS FOR RENOPROTECTION: WHERE WE ARE
Monica Cortinovis, Norberto Perico, Giuseppe Remuzzi
Pharmacological Reviews (2025), pp. 100060-100060
Closed Access
Monica Cortinovis, Norberto Perico, Giuseppe Remuzzi
Pharmacological Reviews (2025), pp. 100060-100060
Closed Access
